Search results for “site:ncbi.nlm.nih.gov”

Page 27 of about 437 results

ncbi.nlm.nih.gov pubmed › 32575016

Fate of respiratory droplets in tropical vs temperate environments and implications for SARS-CoV-2 transmission

The new pandemic of SARS-CoV-2 has shown stark differences in number of affected patients between countries in the tropics and those with temperate environments. Though there have been many theories on reasons for these differences, we...

ncbi.nlm.nih.gov pubmed › 32592496

Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID-19 infection

Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID-19 infection

ncbi.nlm.nih.gov pubmed › 32603802

Corticosteroid administration for viral pneumonia: COVID-19 and beyond

Observational studies showed that corticosteroid treatment was associated with increased mortality and nosocomial infections for influenza and delayed virus clearance for SARS-CoV and MERS-CoV. Limited data on corticosteroid therapy for...

ncbi.nlm.nih.gov pubmed › 32607304

Coronavirus (COVID-19) Fulminant Myopericarditis and Acute Respiratory Distress Syndrome (ARDS) in a Middle-Aged Male Patient

Myopericarditis remains a prominent infectious inflammatory disorder throughout a patient's lifetime. Moreover, viral pathogens have been proven to be the leading contributors to myopericarditis in the pediatric and adult populations....

ncbi.nlm.nih.gov pubmed › 32613083

Black, Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data

<span><b>Background</b>: International and UK data suggest that Black, Asian and Minority Ethnic (BAME) groups are at increased risk of infection and death from COVID-19. We aimed to explore the risk of death in minority ethnic groups in...

ncbi.nlm.nih.gov pubmed › 32619700

CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2

Since the outbreak in 2019, researchers are trying to find effective drugs against the SARS-CoV-2 virus based on de novo drug design and drug repurposing. The former approach is very time consuming and needs extensive testing in humans,...

ncbi.nlm.nih.gov pubmed › 32642390

Rhabdomyolysis in a Patient With Coronavirus Disease 2019

Coronavirus disease 2019 has rapidly enveloped the world in a pandemic after emerging in Wuhan, China, in December 2019. We describe a 49-year-old man presenting with fever, cough, dyspnea, and myalgia diagnosed with coronavirus disease...

ncbi.nlm.nih.gov pubmed › 32652139

Update on neurological manifestations of COVID-19

Novel coronavirus (severe acute respiratory syndrome coronavirus-2: SARS-CoV-2) has a high homology with other cousin of coronaviruses such as SARS and Middle East respiratory syndrome-related coronavirus (MERS). After outbreak of the...

ncbi.nlm.nih.gov pubmed › 32659413

Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19

RT-PCR remains the gold standard for the diagnosis of COVID-19 in sputum samples. However, the combination of different diagnostic tests is highly recommended to achieve adequate sensitivity and specificity.

Try “site:ncbi.nlm.nih.gov” on: Marginalia · Mojeek · Wiby · DuckDuckGo · Bing · Google · Wikipedia · Internet Archive